| P50 | author | Taoufik Alsaadi | Q57080537 |
| P2093 | author name string | Sarah Pirio Richardson | |
| | Sarah Tomaszewski Farias | |
| | Anthony R Lima | |
| P2860 | cites work | Pharmacology of antiepileptic drug polypharmacy | Q73105544 |
| | Patient satisfaction with polypharmacy reduction in chronic epileptics | Q73769911 |
| | Seizure freedom with more than one antiepileptic drug | Q74569865 |
| | Quality of life outcome is associated with cessation rather than reduction of psychogenic nonepileptic seizures | Q30310565 |
| | Antiepileptic drugs: safety in numbers? | Q33896563 |
| | Refractory epilepsy: a progressive, intractable but preventable condition? | Q34123186 |
| | Reducing overtreatment | Q35006402 |
| | How long does it take for partial epilepsy to become intractable? | Q40608293 |
| | Antiepileptic drugs as a cause of worsening seizures | Q41759923 |
| | The problem of intractability: the continuing need for new medical therapies in epilepsy | Q41760373 |
| | Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study | Q43906035 |
| | Levetiracetam monotherapy for adults with localization-related epilepsy | Q46782395 |
| | Reduction of polypharmacy in epileptic patients | Q49228033 |
| | A follow-up study of adults with learning disabilities and epilepsy. | Q51988178 |
| | Patient-validated content of epilepsy-specific quality-of-life measurement. | Q52892849 |
| | Reduction of two-drug therapy in intractable epilepsy | Q70433842 |
| | The relationship between poor medication compliance and seizures | Q73060072 |
| | Lamotrigine monotherapy improves health-related quality of life in epilepsy: a double-blind comparison with valproate | Q73060182 |
| | Epilepsy after the first drug fails: substitution or add-on? | Q73085681 |
| P433 | issue | 3 | |
| P921 | main subject | seizure | Q6279182 |
| P304 | page(s) | 343-347 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Epilepsy Behavior | Q15746410 |
| P1476 | title | Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy | |
| P478 | volume | 5 | |